99
In the present study we therefore investigated the effects of repeated oral administration of MPH 100 on D 2/3 receptor availability in the ventral striatum of high-impulsive rats on the 5-choice serial reaction 101 time task (5-CSRTT). Impulsivity in this task is measured by the number of anticipatory responses to an imminent visual signal and is analogous to false alarms on the analogous continuous performance 103 test in humans (Robbins, 2002 
108

Material and Methods
109
Subjects
110
Ninety-six adult male Lister-hooded rats (Charles River, Margate, UK), weighing 250-275 g and 2-3 111 months of age at the beginning of behavioral training, were used. These were housed in groups of four 112 in enclosed ventilation chambers during the initial training and selection of HI and LI rats. Upon 113 completion of the screening and for the remaining period of the study rats were singly housed (n=8 HI; 
123
The 5-CSRTT apparatus has been described in detail elsewhere (Bari et al., 2008) . The training 124 procedure used in the present study was identical to that previously described (Caprioli et al., 2013) . In 
153
MPH, rats were trained to consume the Ribena solution from a 1 ml syringe. Chronic MPH exposure 154 was maintained for 7 days a week for 4 consecutive weeks (see Figure 1) . During this period, rats
155
were assessed for performance on the 5-CSRTT at 08:00 when rats were in the drug-free state (i.e., extracting the drugs by adding to a pre-conditioned Strata Screen-C GF 200mg/6 mL SPE column.
174
Ritalinic acid was eluted first with hexane/ethyl acetate (50:50) followed by MPH using 
188
CSRTT (see Figure 1 ). The scanning procedure has been described in detail elsewhere (Caprioli et al., 
233
Results
234
Segregation of high and low impulsivity groups
235
The behavioral performance of LI and HI rats on the 5-CSRTT is summarized in Table 1 . Percentage 236 premature responses for HI (n=8) and LI (n=7) rats, averaged across the three L-ITI sessions prior to 237 the commencement of MPH dosing, were 69.6 ± 7.5% (mean ± SEM) and 21.5 ± 2.2%, respectively.
238
HI rats were more impulsive than LI rats regardless of the ITI being set to 5 s ('b1' to 'b10', 'S-ITI' 
243
Interactive effects of methylphenidate on impulsivity in LI and HI rats
244
Twenty one days after the commencement of daily MPH dosing, rats were re-assessed for impulsivity 245 and attentional performance on the 5-CSRTT. It can be seen in Figure 1B that MPH produced 246 divergent effects on impulsivity in the two impulsivity sub-groups with impulsivity appearing to decrease 247 in HI rats but increase in LI rats (group × MPH interaction: F(1,13)=7.59, p=0.016). Although post-hoc 248 t-tests failed to reveal a significant decrease in impulsivity, at a group level, following MPH treatment in
249
HI rats (p=0.095), the increase in impulsivity observed in LI rats was significant (p=0.044). Thus,
250
following exposure to MPH, the initial contrast in impulsivity between LI and HI rats was greatly 251 diminished. Importantly, it can be seen in Figure 1C that MPH increased impulsivity in LI rats in an 252 inverse relationship to the baseline level of impulsivity, while impulsivity decreased in HI rats, with the magnitude of the decrease being positively correlated to the baseline level of impulsivity. Thus, the 254 effect of MPH to increase impulsivity was greatest in LI rats showing the lowest baseline level of 255 impulsivity (r = -0.80; p=0.03) whereas MPH decreased impulsivity to a greater extent in those HI rats
256
showing the highest baseline level of impulsivity (r = -0.7; p=0.05). However, MPH did not restore the 257 attentional inaccuracy of HI rats, which remained significantly impaired relative to LI rats (main effect of 258 group F (1,13) = 3.62, p=0.049; group x MPH interaction: F (1,13) = 0.37, p=0.55). Moreover there were no 259 significant effects of MPH on omissions or magazine latencies on the 5-CSRTT ( Figure 1D and Table   260 1).
261
Modulation of D 2/3 receptor availability in the ventral striatum by MPH
262
Consistent with our recent study (Caprioli et al., 2013) , the availability of D 2/3 receptors was significantly 
272
Baseline-dependent effects of MPH on striatal D 2/3 receptors in high impulsive rats
273
We found no significant group differences in D 2/3 receptor availability between LI and HI rats in the 274 dorsal striatum, either at baseline (pre-MPH) or following MPH treatment (data not shown). However,
275
when we compared the change in [ 
286
We next compared the relative changes in D 2/3 receptor availability and impulsivity produced by
287
MPH treatment (Figure 4) . We found no significant relationship between these parameters in any of the 288 striatal sub-regions examined for either LI rats or HI rats.
289
Discussion
290
This study investigated striatal D 2/3 receptor availability in highly impulsive rats and the mechanisms 291 underlying the therapeutic effects of chronic oral MPH. We found that repeated oral MPH was sufficient 292 to produce bi-directional effects on impulsivity that depended on the baseline level of impulsivity. Thus,
293
in LI rats, MPH increased impulsivity whereas in HI rats it reduced impulsivity in animals exhibiting the 
301
We found a strong inverse relationship between baseline D 2/3 BP ND and the change in this 302 parameter after MPH treatment in HI rats. However no such relationship was found for LI rats in any of 303 the striatal sub-regions examined. These findings correspond with our earlier findings in rats self- 
310
This may explain why cocaine produced a more substantial reduction in impulsivity in the HI sub-group 311 compared with MPH in the present study (Caprioli et al., 2013) .
The mechanism underling the observed rate dependent modulation of impulsivity following MPH 313 treatment is unknown but as discussed above may be distinct for LI and HI rats. Although for LI rats 
346
An analogous PET study in rats found that treating rats with oral MPH for 8 months, initiated during 347 the peri-adolescent period, increased D 2/3 availability in the striatum (Thanos et al., 2007) . By contrast, 
360
There are several limitations of the present study that merit discussion. Firstly, although we dosed
361
MPH orally and assessed serum MPH levels and its metabolite ritalinic acid, as endorsed by others 362 (Volkow and Insel, 2003; Gill et al., 2012) , peak MPH levels were in excess of the typical therapeutic 363 range of MPH of 8 to 10 ng/ml (Swanson and Volkow, 2002) (Table 2) 
